Mon.May 05, 2025

article thumbnail

How long does phenobarbital stay in your system?

The Checkup by Singlecare

Phenobarbital belongs to a drug class called barbiturates , which are primarily used as seizure medications. Barbiturates are sedative-hypnotic medications, meaning they help you feel sleepy and relaxed. Phenobarbital is FDA approved to prevent and treat several types of seizure disorders, including epilepsy and status epilepticus. The anti-epileptic is also used in addiction treatment for the management of withdrawal symptoms associated with benzodiazepine and alcohol dependence.

article thumbnail

New J&J data signals progress in ulcerative colitis treatment landscape

European Pharmaceutical Review

New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.

FDA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With compounders out of the way, Lilly and Novo go after each other

PharmaVoice

The two obesity leaders are pulling on all levers to stay on top of the market.

article thumbnail

Key trends and technologies in drug delivery for 2025 and beyond

European Pharmaceutical Review

Drug delivery technology is undergoing rapid innovation worldwide. Pharmaceutical manufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. In fact, industry analysis shows drug delivery innovation is at an all-time high globally. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: As financial prospects for gene therapies dim, an ambitious charity picks up the torch  

STAT

MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts.  The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.

article thumbnail

Q&A: Pharmacists Play Key Role in Retinal Therapy Support | Asembia 2025

Drug Topics

Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth discusses how pharmacists can reduce patient burden.

More Trending

article thumbnail

After an up and down year, pharma’s R&D landscape is shifting again

PharmaVoice

While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.

article thumbnail

STAT+: 5 food experts making sense of MAHA’s vision for a new way of eating

STAT

Here are a few things we know about how Robert F. Kennedy eats. He likes raw milk , full-fat dairy, and intermittent fasting. He’s suspicious of artificial food dyes and seed oils, and says “ sugar is poison.” He doesn’t drink alcohol. If he spots roadkill, he may try to eat it , though not right away. The health secretary’s personal nutrition views and habits matter because they have direct bearing on the policies of his Make America Healthy Again movement, wh

article thumbnail

Merck Begins Construction on $1 Billion Biologics Manufacturing Hub

PharmExec

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies, including antibody-drug conjugates.

article thumbnail

Chinese regulator grants priority review for InnoCare’s solid tumour treatment

Pharmaceutical Technology

China NMPA's Center for Drug Evaluation (CDE) has granted priority review for InnoCare Pharma's zurletrectinib (ICP-723)

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Coalition of 19 states asks federal judge to reverse deep cuts to HHS

STAT

Attorneys general in 19 states and Washington, D.C., are challenging cuts to the  U.S. Health and Human Services  agency, saying the Trump administration’s  massive restructuring  has destroyed life-saving programs and left states to pick up the bill for mounting health crises. The lawsuit was filed in federal court in Washington D.C. on Monday, New York Attorney General Letitia James said.

article thumbnail

FDA accepts Novo Nordisk’s NDA submission for weight management therapy

Pharmaceutical Technology

The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).

FDA
article thumbnail

Americans would suffer most if Trump imposes pharma tariffs, sector warns

The Guardian - Pharmaceutical Industry

Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients Americans would suffer most if Donald Trump imposed tariffs on imports of pharmaceuticals, as medications would become more expensive and potentially unaffordable for some people, drugmakers have warned. Drugmakers have been braced for targeted border taxes similar to the 25% levies on steel, aluminium and car imports after the US president threatened to hit the sector and announced an

article thumbnail

Trump's budget would be "catastrophic" for federal R&D

pharmaphorum

Trump's 2026 budget request envisages sweeping cuts to funding for the NIH and other federal agencies that will be a disaster, say science advocates

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Hospitals and patient groups ramp up opposition to Medicaid cuts as House mulls options

STAT

WASHINGTON — Hospitals, health centers, and patient advocates this week plan to escalate their pressure on federal lawmakers to oppose cuts to the Medicaid program. The groups are increasing their public calls to lawmakers, standing up new collaborations, and increasing investments in advertising to discourage lawmakers from cutting hundreds of billions of dollars in the program.

article thumbnail

FDA decision on oral Wegovy coming in Q4

pharmaphorum

FDA decision on oral Wegovy coming in Q4 Jonah.

FDA
article thumbnail

FDA will ask outside experts to review Capricor’s therapy for Duchenne muscular dystrophy

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today, we explore how an ambitious nonprofit is taking control of a shelved gene therapy, as it seeks to create a new model for commercializing treatments no longer deemed lucrative by pharma. Also, we see global scientific worry over internal NIH emails that say international collaborations may be cut off.

FDA
article thumbnail

TAE Life Sciences, Ohio State University partner to advance cancer drug development

Pharmaceutical Technology

TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC James to develop boron-based drug compounds for cancer therapy.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Opinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy

STAT

Having grown up in rural Arkansas, I have an acute awareness of the challenges many in our country face when it comes to health care. Quality care wasn’t always accessible, and the decision of whether to pay medical or utility bills was a real dilemma for my family and others in our community. That is why bringing transformational medicines to patients and advocating for policies that ensure these medicines are rapidly and widely available are so important to me and my 30,000 colleagues.

article thumbnail

Sanofi to Fly Meningitis Flag on McLaren Car at 24 Hours of Le Mans

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Women’s Health Initiative — and its 42,000 volunteers — still in limbo

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hi, Morning Rounds editor Karen Pennar, back again. First off, an update to Friday’s newsletter item on NIH’s freeze of subawards to foreign scientists: Megan Molteni has learned that privately, NIH leadership is making it clear that the moves are part of a broader America First agenda that seeks to dramatically reduce U.S. participation in international s

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Since the pandemic, leading health systems have re-organized their leadership and organizational structures to streamline telehealth programs. OSF Healthcare, UPMC and WVU Medicine share their experiences.

article thumbnail

Opinion: STAT+: A court decision on lab-developed tests sets a dangerous precedent

STAT

It’s no secret that the new administration has upset normal operations at the Food and Drug Administration: Thousands of employees have been terminated , more than three dozen senior officials are gone , day-to-day operations ranging from communicating product recalls to the public to inspections of food and drug facilities have been upended , and approvals of new products and technologies have been delayed and shelved.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Health plans and employers view cell and gene affordability as a significant challenge. Next month, the CMS will announce states participating in a new model to address financial concerns by states and payers.

article thumbnail

STAT+: ACA woes, the Texas Medical Parking Center, and a pandemic stock that’s crashed

STAT

This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday.  Sign up here.  President Trump has threatened to revoke Harvard’s tax-exempt status. Zero indication how or on what grounds he could do so. Could this mean anything for the tax-exempt hospital crowd? The line is open: bob.herman@statnews.com or bobjherman.09 on Signal.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Virtual MSK provider IncludeHealth rebrands as LainaHealth as the business enters a new chapter, building out its capabilities in computer vision and AI.

article thumbnail

6 Free Hematology & Oncology Board Review Practice Questions

Board Vitals - Pharmacist

The American Board of Internal Medicine (ABIM) Hematology and Oncology board exams are coming up. Don’t fret, we’re here to help you prepare with some HemOnc practice questions. All the information covered on the exams are things you already know, but you just need to be able to recall it at a moment’s notice. To ensure a good prognosis, you just need to practice.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year-over-year to reach $586 million.

article thumbnail

Q&A: Smarter Pharmacy Tools Are Making Patient Care Faster, Simpler | Asembia 2025

Drug Topics

Sarah Thomas and David Skomo of HealthDyne discuss some of the most useful innovations that have been helpful for pharmacies.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The besieged federal consumer watchdog has officially switched sides on a lawsuit seeking to abolish a Biden-era restriction on including medical debt in credit reports.

article thumbnail

STAT+: Charles Lieber, ex-Harvard chemist convicted of lying about ties to China, joins faculty of Chinese university

STAT

Charles Lieber, the former chair of Harvard’s chemistry department and renowned nanoscientist who was  convicted of lying to federal agents about his ties to China , was recently announced as a new professor at a Chinese university. Lieber joined the full-time faculty at Tsinghua Shenzhen International Graduate School on April 28 and was appointed to Tsinghua University‘s highest faculty position, the university  announced  this month.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Function Health, a preventive health and longevity startup, acquired Ezra to integrate Functions lab testing capabilities with the companys artificial intelligence-powered full-body scans, combining two emerging health trends into one company.

article thumbnail

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Pharmacy Times

This installment of our series on ADCs and HER2 breast cancer offers key insights about novel agents in clinical trials and management of ADC therapies.